Rating History for Hepion Pharma (HEPA) by Brookline Capital Markets

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/7/2023 Kumaraguru Raja Downgrade Hold
(Buy)
N/A
(N/A)
3.24
(0.32)
-90.12% Details